{"id":5016,"date":"2025-12-25T14:55:14","date_gmt":"2025-12-25T14:55:14","guid":{"rendered":"https:\/\/regenerated.health\/peptide-protocols\/"},"modified":"2026-06-25T14:04:10","modified_gmt":"2026-06-25T14:04:10","slug":"peptide-protocols","status":"publish","type":"post","link":"https:\/\/regenerated.com\/blog\/peptide-protocols\/","title":{"rendered":"Peptide Protocols: Dosing, Cycling, and Stacking"},"content":{"rendered":"\n

At a Glance<\/strong>

\u2022 Peptide protocols define how peptides are dosed, timed, cycled, and combined for specific therapeutic goals
\u2022 Some peptides require cycling (GH secretagogues) to prevent receptor desensitization – others are used continuously until the goal is reached (BPC-157)
\u2022 Stacking means combining complementary peptides for synergistic effects – common examples include BPC-157 + TB-500 and Ipamorelin + CJC-1295
\u2022 “More is not better” – exceeding recommended doses typically increases side effects without proportional benefit
\u2022 Safety monitoring (bloodwork, IGF-1 levels) is essential for growth hormone-related protocols
\u2022 Protocols should be individualized by a knowledgeable practitioner based on your health goals, labs, and response<\/p>\n\n\n\n

\n\n\n\n

What Makes a Peptide Protocol?<\/h2>\n\n\n\n

A peptide protocol is the structured plan that defines exactly how a peptide – or combination of peptides – is used to achieve a specific therapeutic outcome. It covers the dose, the frequency, the duration, cycling patterns, and any complementary peptides used together.<\/p>\n\n\n\n

If the peptide is the tool, the protocol is the blueprint. The same peptide can produce very different results depending on how it is used. A BPC-157 protocol for healing a torn rotator cuff looks different from one targeting gut repair. An ipamorelin protocol for anti-aging optimization differs from one designed as a short-term recovery intervention.<\/p>\n\n\n\n

This guide covers how experienced practitioners structure peptide protocols – including the reasoning behind cycling, stacking, dosing schedules, and the monitoring that keeps everything safe. If you are new to peptide therapy, we recommend starting with our thorough Peptide Therapy pillar guide<\/a> before diving into protocol specifics.<\/p>\n\n\n\n

Cycling: Why Timing On and Off Matters<\/h2>\n\n\n\n

Cycling refers to alternating periods of active peptide use (“on” periods) with rest periods (“off” periods). Not every peptide requires cycling, and understanding which do – and why – is critical to getting good results.<\/p>\n\n\n\n

Peptides That Benefit From Cycling<\/h3>\n\n\n\n

Growth hormone secretagogues (Ipamorelin, CJC-1295, GHRP-6, MK-677)<\/strong> are the primary category where cycling is important. The reason is receptor desensitization<\/strong>: with continuous, prolonged use, the receptors these peptides act on can become less responsive over time. You end up needing more to get the same effect – the classic pattern of diminishing returns.<\/p>\n\n\n\n

A typical cycling pattern for GH secretagogues is 5 days on \/ 2 days off<\/strong> or 8-12 weeks on \/ 4 weeks off<\/strong>. The rest period allows receptor sensitivity to reset, so when you resume, the peptide works effectively at the same dose.<\/p>\n\n\n\n

PT-141 (Bremelanotide)<\/strong> also requires spacing. The FDA recommends no more than 8 doses per month, and not more than one dose in 24 hours. Tachyphylaxis (rapid tolerance) can develop with too-frequent use.<\/p>\n\n\n\n

Peptides That Typically Do Not Require Cycling<\/h3>\n\n\n\n

BPC-157<\/strong> is generally used continuously throughout the healing period. Because it works through multiple mechanisms (angiogenesis promotion, growth factor modulation, nitric oxide system regulation) rather than a single receptor pathway, desensitization is not a significant concern. Most practitioners prescribe it for a defined treatment course – typically 4-12 weeks – based on the injury being treated, then discontinue once healing goals are met.<\/p>\n\n\n\n

Thymosin Alpha-1<\/strong> is often used in extended courses for immune modulation without cycling, as its mechanism of action does not appear to produce significant receptor desensitization.<\/p>\n\n\n\n

Semaglutide<\/strong> is used continuously as a long-term therapy for weight management or metabolic health. Cycling is not part of the standard protocol – discontinuation typically leads to weight regain if lifestyle modifications are not maintained.<\/p>\n\n\n\n

Peptide<\/th>Cycling Needed?<\/th>Typical Pattern<\/th>Rationale<\/th><\/tr><\/thead>
Ipamorelin<\/strong><\/td>Yes<\/td>5 on \/ 2 off or 8-12 weeks on \/ 4 weeks off<\/td>Prevent GH receptor desensitization<\/td><\/tr>
CJC-1295 (no DAC)<\/strong><\/td>Yes<\/td>Same as Ipamorelin (often paired)<\/td>Prevent GHRH receptor desensitization<\/td><\/tr>
CJC-1295 (with DAC)<\/strong><\/td>Yes<\/td>8-12 weeks on \/ 4 weeks off<\/td>Long-acting – cycling prevents sustained receptor downregulation<\/td><\/tr>
MK-677<\/strong><\/td>Recommended<\/td>8-12 weeks on \/ 4-8 weeks off<\/td>Sustained GH elevation may affect insulin sensitivity<\/td><\/tr>
BPC-157<\/strong><\/td>No<\/td>Continuous for 4-12 weeks, then stop<\/td>Goal-based duration; no significant desensitization<\/td><\/tr>
TB-500<\/strong><\/td>No (but phased)<\/td>Loading phase then maintenance (see below)<\/td>Front-loads healing stimulus, then tapers<\/td><\/tr>
Semaglutide<\/strong><\/td>No<\/td>Ongoing as prescribed<\/td>Continuous use for sustained metabolic benefits<\/td><\/tr>
PT-141<\/strong><\/td>Yes (by design)<\/td>As needed, max 8 doses\/month<\/td>Tachyphylaxis with frequent use<\/td><\/tr>
Thymosin Alpha-1<\/strong><\/td>No<\/td>Extended courses as prescribed<\/td>Immune modulation without significant desensitization<\/td><\/tr>
Selank \/ Semax<\/strong><\/td>Optional<\/td>4-6 weeks on \/ 2-4 weeks off if cycling<\/td>Some practitioners cycle to assess ongoing need<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n

Stacking: Combining Peptides for Synergistic Results<\/h2>\n\n\n\n

Stacking refers to using two or more peptides simultaneously, chosen to complement each other’s mechanisms. When done thoughtfully, stacking can produce results greater than either peptide alone. When done carelessly, it just increases cost and complexity without meaningful benefit.<\/p>\n\n\n\n

Here are the most evidence-supported and clinically common stacks:<\/p>\n\n\n\n

Stack 1: BPC-157 + TB-500 – The Injury Healing Powerhouse<\/h3>\n\n\n\n

This is arguably the most popular peptide stack in regenerative medicine. The rationale is straightforward: BPC-157 and TB-500 promote tissue healing through different but complementary pathways.<\/p>\n\n\n\n

BPC-157<\/strong> promotes angiogenesis (new blood vessel formation), modulates growth factor expression, and has potent anti-inflammatory effects concentrated at the site of injury. It excels at tendon, ligament, muscle, and gut healing.<\/p>\n\n\n\n

TB-500 (Thymosin Beta-4)<\/strong> promotes cell migration to injury sites, reduces inflammation systemically, and supports tissue remodeling. It has a broader, more systemic healing effect.<\/p>\n\n\n\n

Together, they address both the localized healing environment (BPC-157) and the systemic recovery support (TB-500). Many practitioners report that the combination produces noticeably faster and more complete healing than either peptide alone.<\/p>\n\n\n\n

Typical protocol:<\/strong> BPC-157 at 250-500mcg twice daily (SubQ, ideally near the injury), plus TB-500 at 750mcg twice weekly for the first 4-6 weeks (loading), then 750mcg once weekly for maintenance. Duration: 6-12 weeks depending on the injury.<\/p>\n\n\n\n

Stack 2: Ipamorelin + CJC-1295 (no DAC) – Growth Hormone Optimization<\/h3>\n\n\n\n

This is the gold-standard combination for stimulating your body’s natural growth hormone production. The two peptides work on different receptors in the GH signaling cascade:<\/p>\n\n\n\n

CJC-1295 (without DAC)<\/strong> is a GHRH (growth hormone-releasing hormone) analog. It acts on the GHRH receptor in the pituitary to prime the system for GH release.<\/p>\n\n\n\n

Ipamorelin<\/strong> is a ghrelin mimetic that acts on the GHS receptor. It provides the direct “pulse” signal to release growth hormone.<\/p>\n\n\n\n

Think of CJC-1295 as setting the stage and ipamorelin as triggering the curtain rise. Together, they produce a more strong, physiologically natural GH pulse than either peptide alone, without the broad hormonal disruption of synthetic HGH.<\/p>\n\n\n\n

Typical protocol:<\/strong> CJC-1295 at 100mcg + Ipamorelin at 200-300mcg, combined in the same syringe, injected SubQ at bedtime on an empty stomach. 5 days on \/ 2 days off. Cycle: 8-12 weeks on, 4 weeks off.<\/p>\n\n\n\n

Stack 3: Selank + Semax – Cognitive Enhancement<\/h3>\n\n\n\n

For cognitive optimization, this Russian-developed duo targets different but complementary neural pathways:<\/p>\n\n\n\n

Selank<\/strong> is derived from tuftsin and has anxiolytic (anti-anxiety) properties plus immune-modulating effects. It supports cognitive function by reducing the background noise of anxiety and stress that impairs focus and memory.<\/p>\n\n\n\n

Semax<\/strong> is derived from ACTH(4-10) and has direct nootropic and neuroprotective effects. It enhances BDNF (brain-derived neurotrophic factor) expression, supports attention and memory, and has been used clinically for cognitive decline and stroke recovery.<\/p>\n\n\n\n

Together, Selank calms and stabilizes while Semax sharpens and enhances – a combination that many users describe as “clear-headed focus without jitteriness.”<\/p>\n\n\n\n

Typical protocol:<\/strong> Selank 300-600mcg intranasally, 2-3 times daily. Semax 200-600mcg intranasally, 2-3 times daily. Often used in 4-6 week courses. Both are nasal sprays, so no injection is needed.<\/p>\n\n\n\n

Stack 4: BPC-157 + Ipamorelin + CJC-1295 – Healing + Recovery<\/h3>\n\n\n\n

This triple stack is sometimes used for athletes or individuals recovering from significant injury or surgery where both accelerated tissue healing and the regenerative benefits of optimized growth hormone are desired. The GH secretagogues support the systemic recovery environment while BPC-157 targets localized tissue repair.<\/p>\n\n\n\n

Typical protocol:<\/strong> BPC-157 at 250-500mcg twice daily (ongoing), plus Ipamorelin 200-300mcg + CJC-1295 100mcg at bedtime (cycled 5\/2). Duration depends on recovery needs, typically 8-12 weeks.<\/p>\n\n\n\n

Key Concept: More Is Not Better<\/strong>

One of the most important principles in peptide therapy is that exceeding recommended doses does not produce proportionally better results – but it does produce proportionally more side effects. Growth hormone secretagogues at excessive doses can cause water retention, joint pain, carpal tunnel symptoms, and insulin resistance. BPC-157 at megadoses has not been shown to heal faster than standard doses. Stick to evidence-based dosing ranges and trust the process. The body’s receptor systems have saturation points, and pushing past them creates diminishing returns at increasing cost to your comfort and safety.<\/p>\n\n\n\n

Comprehensive Dosing Schedule Reference<\/h2>\n\n\n\n
Peptide<\/th>Typical Dose<\/th>Frequency<\/th>Timing<\/th>Duration<\/th><\/tr><\/thead>
BPC-157<\/strong><\/td>250-500mcg<\/td>2x daily<\/td>Morning and evening<\/td>4-12 weeks (until healed)<\/td><\/tr>
TB-500<\/strong><\/td>750mcg<\/td>2x\/week (loading), 1x\/week (maint.)<\/td>Any time<\/td>6-12 weeks<\/td><\/tr>
Ipamorelin<\/strong><\/td>200-300mcg<\/td>1x daily, 5 days on \/ 2 off<\/td>Bedtime, empty stomach<\/td>8-12 weeks, then 4 weeks off<\/td><\/tr>
CJC-1295 (no DAC)<\/strong><\/td>100mcg<\/td>1x daily, 5 days on \/ 2 off<\/td>Bedtime, with Ipamorelin<\/td>8-12 weeks, then 4 weeks off<\/td><\/tr>
CJC-1295 (with DAC)<\/strong><\/td>1,000-2,000mcg<\/td>1-2x per week<\/td>Any time<\/td>8-12 weeks, then 4 weeks off<\/td><\/tr>
MK-677<\/strong><\/td>10-25mg (oral)<\/td>1x daily<\/td>Bedtime<\/td>8-12 weeks on, 4-8 weeks off<\/td><\/tr>
Semaglutide<\/strong><\/td>0.25mg-2.4mg<\/td>1x per week<\/td>Same day each week<\/td>Ongoing as prescribed<\/td><\/tr>
PT-141<\/strong><\/td>1.75mg<\/td>As needed<\/td>45 min before activity<\/td>Max 8 doses\/month<\/td><\/tr>
Thymosin Alpha-1<\/strong><\/td>1.6mg<\/td>2-3x per week<\/td>Any time<\/td>Extended courses as prescribed<\/td><\/tr>
Selank<\/strong><\/td>300-600mcg<\/td>2-3x daily (intranasal)<\/td>As needed throughout day<\/td>4-6 week courses<\/td><\/tr>
Semax<\/strong><\/td>200-600mcg<\/td>2-3x daily (intranasal)<\/td>Morning and afternoon<\/td>4-6 week courses<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n

\u26a0 Safety Warning: These Are General Ranges, Not Prescriptions<\/strong>

The dosing information in this guide represents commonly reported clinical ranges for educational purposes. Individual dosing should always be determined by your prescribing practitioner based on your body weight, health status, goals, lab results, and response to therapy. Do not self-prescribe peptide protocols based on internet information alone.<\/p>\n\n\n\n

Loading vs. Maintenance Phases<\/h2>\n\n\n\n

Several peptide protocols distinguish between an initial loading phase and an ongoing maintenance phase. This approach front-loads the therapeutic stimulus to establish an effect, then reduces the dose or frequency to sustain it.<\/p>\n\n\n\n

TB-500 Loading Protocol<\/h3>\n\n\n\n

TB-500 is the classic example of a loading\/maintenance approach:<\/p>\n\n\n\n